Drug reference
Prophylaxis of asthma ▶BY INHALATION OF AEROSOL ▶Child 5–17 years: Initially 4 mg 4 times a day, when control achieved may be possible to reduce to twice daily ▶Adult: Initially 4 mg 4 times a day, when control achieved may be possible to reduce to twice daily DOSE EQUIVALENCE AND CONVERSION ▶2 puffs = 4 mg. l UNLICENSED USE ▶In children Not licensed for use in children under 6 years.
PDF page 307
Flavours of inhalers may include mint.
PDF page 307
MHRA/CHM ADVICE: PRESSURISED METERED DOSE INHALERS (PMDI): RISK OF AIRWAY OBSTRUCTION FROM ASPIRATION OF LOOSE OBJECTS (JULY 2018) See Respiratory system, drug delivery p. 249.
PDF page 307
▶Common or very common Bronchospasm. cough. gastrointestinal discomfort. headache. nausea. taste altered. vomiting ▶Frequency not known Pharyngitis. throat irritation SIDE-EFFECTS, FURTHER INFORMATION If paradoxical bronchospasm occurs, a fast-acting inhaled bronchodilator such as salbutamol or terbutaline should be used to control symptoms; treatment with nedocromil should be discontinued.
PDF page 307
Inhaled drugs can be taken as normal during pregnancy.
PDF page 307
Inhaled drugs can be taken as normal during breast-feeding.
PDF page 307
There can be variation in the licensing of different medicines containing the same drug. Pressurised inhalation CAUTIONARY AND ADVISORY LABELS 8 ▶Tilade (Sanofi) Nedocromil sodium 2 mg per 1 dose Tilade 2mg/dose inhaler CFC free | 112 dose P £39.94 DT = £39.94
PDF page 307
Withdrawal should be done gradually over a period of one week—symptoms of asthma may recur.
PDF page 307
Regular use is necessary. Patient counselling is advised for Nedocromil aerosol for inhalation (administration).
PDF page 307
Initially 4 mg 4 times a day, when control
First-line fragment. Read the complete Indications and Dose section above.
PDF page 307
